Cardiac Prosthetic Devices Market, By Product Type (Heart Valves (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves), Pacemaker (Implantable Pacemaker, External Pacemaker)), By End User (Hospital, Specialty Centers, Others), and By

Cardiac Prosthetic Devices Market, By Product Type (Heart Valves (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves), Pacemaker (Implantable Pacemaker, External Pacemaker)), By End User (Hospital, Specialty Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cardiac Prosthetic Devices comprises of prosthetic heart valves such as mechanical heart valve and tissue heart valve along with annuloplasty rings, pacemaker leads, defibrillator leads, tissue patches, ventricular assist devices, and artificial hearts. These are used to replace damaged or diseased natural valves of the heart. Increasing prevalence of hypertension is expected to propel growth of the global cardiac prosthetic devices market over the forecast period. Furthermore, increasing research and product launches is also anticipated to assist the growth of the market.
Key features of the study:
This report provides in-depth analysis of the Global Cardiac Prosthetic Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Cardiac Prosthetic Devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios, Lepu Medical, Lifetech Scientific, LivaNova, MEDICO, Medtronic plc, Meril Life Sciences, MicroPort Scientific, Shree Pacetronix, TTK Healthcare, Venus Medtech, and Vitatron.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Cardiac Prosthetic Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cardiac Prosthetic Devices market
Detailed Segmentation:
Global Cardiac Prosthetic Devices Market, By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
Global Cardiac Prosthetic Devices Market, By End User:
Hospital
Specialty Centers
Others
Global Cardiac Prosthetic Devices Market, By Region:
North America
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
U.S.
Canada
Latin America
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Product Type:
Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
Transcatheter Heart Valves
Pacemaker
Implantable Pacemaker
External Pacemaker
By End User
Hospital
Specialty Centers
Others
By Country
North Africa
Central Africa
South Africa
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abiomed, Inc.
AtriCure, Inc.
Boston Scientific Corporation
Edward Lifesciences Corporation
BIOTRONIK
Braile Biomedica
CryoLife, Inc.
Labcor Laboratrios
Lepu Medical
Lifetech Scientific
LivaNova
Medtronic plc.
Meril Life Sciences
MicroPort Scientific
Shree Pacetronix
TTK Healthcare
Venus Medtech
Vitatron
“*” marked represents similar segmentation in other categories in the respective section.